These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 16931953

  • 1. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
    Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B.
    Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
    [Abstract] [Full Text] [Related]

  • 2. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN, Jordan TW.
    Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
    [Abstract] [Full Text] [Related]

  • 3. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B, Sika-Paotonu D, Bethwaite PB, William Jordan T, Magi-Galluzzi C, Zhou M, Samaratunga H, Srigley JR.
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [Abstract] [Full Text] [Related]

  • 4. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
    Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM.
    Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
    [Abstract] [Full Text] [Related]

  • 5. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV.
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA.
    Cancer; 2008 Aug 01; 113(3):477-83. PubMed ID: 18484589
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
    Brookman-May S, May M, Zigeuner R, Shariat SF, Scherr DS, Chromecki T, Moch H, Wild PJ, Mohamad-Al-Ali B, Cindolo L, Wieland WF, Schips L, De Cobelli O, Rocco B, Santoro L, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Dalpiaz O, Hohenfellner M, Gilfrich C, Wirth MP, Burger M, Pahernik S, CORONA Project (Collaborative Research on Renal Neoplasms Association).
    J Urol; 2011 Dec 01; 186(6):2175-81. PubMed ID: 22014800
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Allhoff EP, Schips L, Zigeuner R, Figlin RA, Kabbinavar FF, Pantuck AJ, Belldegrun AS, Lam JS.
    J Urol; 2007 Jul 01; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [Abstract] [Full Text] [Related]

  • 17. Multi-institutional validation of a symptom based classification for renal cell carcinoma.
    Patard JJ, Leray E, Cindolo L, Ficarra V, Rodriguez A, De La Taille A, Tostain J, Artibani W, Abbou CC, Guillé F, Chopin DK, Lobel B.
    J Urol; 2004 Sep 01; 172(3):858-62. PubMed ID: 15310983
    [Abstract] [Full Text] [Related]

  • 18. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes.
    Leroy X, Zini L, Leteurtre E, Zerimech F, Porchet N, Aubert JP, Gosselin B, Copin MC.
    Mod Pathol; 2002 Nov 01; 15(11):1126-30. PubMed ID: 12429790
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H, Lindner V, de Fromont M, Molinié V, Letourneux H, Meyer N, Martin M, Jacqmin D.
    Cancer; 2005 Feb 01; 103(3):625-9. PubMed ID: 15611969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.